Not Signed In - Innocoll Receives BfArM Approval For A New Version Of Its CollaRx(R) Gentamicin Surgical Implant In Germany
Tue, 06 Feb 2007 08:00 AM EST
... Innocoll, Inc. announced its sales and marketing subsidiary, Innocoll Pharmaceuticals Ltd., has received approval from The Federal Institute for Drugs and Medical Devices (BfArM) for marketing a new version of its CollaRx(R) GENTAMICIN SURGICAL IMPLANT in Germany, where it is sold under the trade name Sulmycin(R) Implant E. [click link for full article] ...
Related Topics
- Breast Implants
- Cochlear Implants
- Gentamicin Topical
- Lp(a)
- Vaccine Testing & Approval
- Germany
- Leuprolide Implant
- Goserelin
- Mammograms
- Breast Implants/Breast Reconstruction
- Surgical Drains
- Infection of the surgical wound
- Complications
- Scarring or complications after surgical removal
- Endometriosis
- Chlorhexidine Dental Implant
- Surgical complications, including failure of the Kasai procedure
- Silicone
- Gentamicin Ophthalmic Drops or Ointment
- Tarceva
email this page
print this page
bookmark this page
feedback on this page
